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 ABSTRACT 
Ulcerative colitis is a chronic idiopathic inflammatory bowel disease with a 
relapsing nature. It is a very challenging disease affecting a patient during the 
most active period of his life i.e. 20 to 40 years of age. The main features are ano-
rectal bleeding with increased frequency of bowel evacuation, general debility 
and abnormal structural pathology in the descending colon, particularly sigmoid 
colon. In modern medical science, there is no permanent curative treatment for 
this disease. This study can be helpful for reducing the need of steroids and 
surgical processes in the patients of ulcerative colitis. A clinical study of 5 patients 
of ulcerative colitis has been conducted at the O.P.D. and I.P.D. SKAMC & RH, 
Bangalore. They were treated with Pichha basti for 8 days in Yoga basti schedule. 
Results were analyzed statistically by using the ‘t’ test. In this study, it was 
observed that the symptoms and signs were reduced by more than 73% with a 
highly significant result. 
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INTRODUCTION 
Ulcerative colitis (UC) and Crohn's 
disease (CD) are chronic inflammatory bowel 
diseases which pursue a protracted relapsing 
and remitting course, usually extending over 
years.1 Ulcerative colitis, a disorder in which 
inflammation affects the mucosa and submucosa 
of the colon. 
The rapid changes in incidence and 
prevalence in Asia may point to environmental 
changes associated with the ‘Westernisation’ of 
lifestyle (e.g. dietary changes, smoking, etc.) as 
potential risk factors2. Its incidence is more 
during 20 to 40 years of age and men are slightly 
more likely to be affected with UC.  
The major symptoms of UC are 
diarrhoea, rectal bleeding, tenesmus, passage of 
mucus, and crampy abdominal pain3. The 
severity of symptoms correlates with the extent 
of disease. Although UC can present acutely, 
symptoms usually have been present for weeks 
to months. Occasionally, diarrhoea and bleeding 
are so intermittent and mild that the patient 
does not seek medical attention. The first attack 
is usually the most severe and thereafter the 
disease is followed by relapses and remissions. 
Ulcerative colitis can be associated with 
complications like massive haemorrhage, toxic 
mega colon, perforation, stricture and colo-rectal 
carcinoma. 
  Ulcerative colitis only involves the colon, 
particularly the sigmoid colon. According to 
Ayurveda, Pakvashya and Sthula guda are the 
mulasthana for Purishavaha srotas4. So this 
disease can be considered under Purishavaha 
srotas and can be correlated with Raktatisra. 
Pichha basti is mentioned as a management of 
Raktatisara in Charaka Samhita5. 
AIMS AND OBJECTIVES 
To evaluate the efficacy of Pichha basti in 
the management of ulcerative colitis. 
MATERIALS & METHODS 
The present study is an observational 
study with open label study design. All subjects 
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were administered Pichha basti for a period of 8 
days. Pichha basti is prepared as per the 
description in Charaka samhita chikitsa sthana. 
Formulated products purchased from the 
approved pharmacy stores manufactured by 
approved pharmaceutical manufacturers. 
Selection of patient: An open, randomized, 
clinical study was conducted on 5 patients 
diagnosed as Ulcerative colitis and selected from 
OPD & IPD of SKAMC & RH, Bangalore. 
Subjective Parameter 
 Bowel frequency 
 Blood in stool 
 Abdominal pain 
 Weakness  
Objective Parameter 
 Red blood cells in stool 
 Pus cells in stool 
Assessment criteria 
Improvements in the patients were 
assessed on the basis of relief in the subjective 
and objective parameters. All the subjective and 
objective parameters were scored and assessed 
before as well as after the treatment.  
Gradation of subjective & objective parameters 
1. Bowel frequency 
0 = 1or 2 times in a day  
1 =3 or 4 times in a day  
2 =5 or 7 times in a day   
3 =8 or 12 times in a day 
4 = More than 12 times in a day 
2. Blood in stool   
0 =No bleeding     
1 =Occasional bleeding in stool (not daily)  
2 =Bleeding daily but less than 4times per day 
3 = Bleeding daily but less than 8times per day 
4 =Bleeding daily more than 8times per day 
3. Abdominal pain 
0 = No pain     
1 = Tolerable pain    
2 = Mild pain     
3 = Moderate pain    
4= Severe pain  
4. Weakness  
0 = No weakness    
1 = Tolerable weakness   
2 = Mild weakness  
3 = Moderate weakness 
4 = Severe weakness 
5. Red blood cells in stool 
0 = No RBC in stool    
1 = Less than 15/hpf   
2 = 16-30/hpf   
3 = 31-50/hpf  
4 = Plenty or more than 50/hpf 
6. Pus cells in stool 
0 = No pus cells in stool 
1 = Pus cell Less than 15/hpf 
2 = Pus cell 16-30/hpf 
3 = Pus cell 31-50/hpf 
4 = Plenty or more than 50/hpf Pus cell 
Sample Size and Method 
Sample size: 5 without any drop outs. 
Study design: Open level clinical trial  
Number of groups: Single arm 
Drug schedule and Dosage  
Niruha basti  Anuvasna basti  
Madhu =100ml  Jatayadi taila 
60ml with a 
pinch of 
Saindhava 
Saindhava =6gms 
Sneha = Jatayadi 
taila=60ml+Changeari 
gritha = 60ml 
Kalka = Yastimadhu 
choorna (20gm) + 
Pushyanuga choorna 
(20gm) 
Kwatha = Shalmalii twak + 
Yastimadhu sidhha ksheera 
paka = 240ml  
Procedure 
Poorva karma - Sthanika abhayanga with 
Moorchita tila taila and Nadi sweda. 
Pradhana karma - Patient was made to lie in 
left lateral position for administration of Basti. 
Niruha basti was given with empty stomach and 
Anuvasana basti after the food.  
Paschata karma - lift the legs, patting to the 
buttocks, and anti-clockwise massage to 
abdomen. 
Duration of Treatment: = 8 days in Yoga basti 
schedule. 
Inclusion criteria 
 Diagnosed cases of ulcerative colitis 
 Patient who are fit for Basti karma 
Exclusion criteria 
 Patients who had undergone surgeries 
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 Patients who had complications like anal 
fistula etc. 
 Investigations: Stool examination 
OBSERVATIONS & RESULT  
Out of 5 patients, 1 (20%) patient was 
female and 4 (80%) patients were male; all the 
patient (100%) were between the age group of 
25-30, with regards to addictions, 3 (60%) 
patients were non smoker, 2 (40%) patients 
were ex-smoker and all the 5 (100%) patients 
were used to take spicy food. 3 (60%) patients 
belonged to the 1to 2years of chronicity, 2 (40%) 
patients were found in 3 to 5 years of chronicity 
group. 
Bowel frequency was reduced by 81%, 
Bleeding in stool was reduced by 80%, 
Abdominal pain was reduced by 87%, Weakness 
was reduced by 73%, RBC in stool was 
decreased by 85%, Pus cells in stool were 
decreased by 83%. These all parameters showed 
statistically highly significant result. 
Table 2: Changes in before treatment & after treatment (n=5) 
Parameter 
Mean  
Improvement (%) SD SE 
t -
value 
P-
value BT AT 
Bowel frequency 3.2 0.8 81`% 0.5477 0.2739 10.61 <0.001 
Blood in stool  3 0.4 80% 0.5477 0.2739 9.798 <0.001 
Abdominal pain 3 0.4 87% 0.5477 0.2739 9.494 <0.001 
Weakness 2.8 0.4 73% 0.4472 0.2 9 <0.001 
Red blood cells in stool 2.4 0.4 85% 0.4472 0.2 11 <0.001 
Pus cells in stool 2.4 0.4 83% 0.7071 0.3162 6.325 <0.001 
 
 
Graph: Shows improvement in the treatment in before treatment and after treatment
DISCUSSION 
Ulcerative colitis is a mucosal disease 
that usually involves the rectum and extends 
proximally to involve all part of colon. The cause 
is unknown, but several theories have been put 
forward of which the main ones are infective, 
nutritional, psychosomatic & immunological. 
According to Ayurveda, we can consider this 
disease under Purisha vaha srotas due to 
involvement of mainly Sthula guda and its 
treatment was explained as Atisara chikitsa. 
Basti is the best mode of administration 
of the drug as Acharya Charaka has quoted ‘the 
medicine administered through anus is more 
effective in the disorder of Pakvashya. In Vata or 
Vatapitta pradhana atisara, Basti is indicated to 
overcome the disease and at the same time it 
gives Bala to Kati, Pakvashaya sthana6. 
According to Sushruta samhita, Taila avcharana 
in the form of Pichu, Seka & Anuvasana basti is 
indicated in Guda dourbalaya. Pichha basti is 
indicated in Alpa-alpa, or Bahu raktapravruti, 
Sashoola, Vayu vibdhata like conditions7. 
Especially when Ruja lakshana is dominant then 
mainly Pichha basti is indicated8. 
In this present study, the drugs used for 
Pichha basti are Madhu, Saindhava, Jatayadi 
Taila, Changeri Ghrita, Yashtimadhu Choorna, 
Pushyanuga Choorna for Kalka and Shalmali 
twak with Yashtimadhu siddha ksheera paka for 
Kwatha and Jatyadi taila for Anuvasana basti. 
Madhu is Sheeta veerya and Madhura 
rasa, Kashaya anurasa with Shodhana, Ropana 
properties. So its Ropana property helps to heal 
the ulcer. Jatyadi taila (JT), by its best 
Vranaropaka property heals the ulceration and 
0
0.5
1
1.5
2
2.5
3
3.5
Bowel 
frequency
Blood in 
stool 
Abdominal 
pain
Weakness Red blood 
cells in stool
Pus cells in 
stool
BT
AT
Chiterlekha et al. Efficacy of Pichha Basti in Ulcerative Colitis: An Observational Study 
 Available online at : http://ijapr.in Page 26 
its Raktastambhana property provides 
haemostasis. The phytochemical evaluation of 
Jatyadi taila has revealed presence of 
flavonoids, essential oils, tannins, glycosides, 
steroids and alkaloids. Tannins & phytosterols 
promote the wound healing process with 
increased capillary formation & fibroblast 
proliferation enhancing the rate of 
epithelisation.  
The drugs in Changeri ghrita are having 
Shothahara, Vranaropaka and Raktasthabhaka 
properties which are helpful in this disease. 
Yastimadhu is having properties like 
Vatapittajit, Raktaprasadana, Balya, Varnya and 
Madhura rasa, Madhura vipaka with Sheeta 
veerya. Due to presence of Glycyrrhizin, this is a 
gastroprotective and increases the rate of 
mucus secretion by the gastric mucosa. The 
anti-allergic properties of Yashtimadhu have 
been attributed to the corticosteroid-like 
activity of glycyrrhizin and glycyrrhetic acid, 
also known as enoxolone. Pushyanug Churna is 
potent as antibacterial and is mainly indicated 
in Rakta atisara and Rakta arshas. 
For Kwatha purpose, Shalmali is used 
which is having Madhura rasa, Madhura vipaka, 
Sheeta veerya, Snigdha, Pichhala guna. 
Yashtimadhu siddha ksheera paka in that 
Ksheera which contains Madhura rasa, Sheeta 
veerya, Pichchil guna and indicated in Vata, 
Pitta, Rakta atisara. So using Ksheera paka with 
Yashtimadhu is more effective.  
So the drugs used in Basti Karma are 
having combined effect like Vata pitta shamana, 
Rakta sthambhana, Vrana shodhana and Vrana 
ropana. 
CONCLUSION 
Basti karma has shown improvement or 
cure of the ulcerations of the bowel by enhanced 
healing and subsiding inflammation & 
irritability of the colon. It also improves 
functions of Apana Vayu, situated in 
Pakwashaya and results into improvement of 
ulcerations and regulation of evacuation of the 
colon. In the present study the mean scores of 
frequency of diarrhoea, blood and mucous in 
stool, pain abdomen, weakness, pus cell in stool 
are compared to before and after treatment 
is highly significant. Keeping in mind the 
complications of surgical management, this 
Pichha basti is definitely a better option. 
Although the number of patients included in this 
study was small, but this study provides a basis 
for further evaluation by a large longitudinal 
study to substantiate its findings. 
ACKNOWLEDGEMENTS 
Dr. N.Anjaneya Murthy, Dean, Dept of P.G 
studies, SKAMCH & RC. 
Dr. Kiran.M.Goud, Principal, SKAMCH & RC, 
Vijayanagar, Bangalore. 
REFERENC ES 
1. Sir Stanley Davidson, Davidson’s Principal 
and practice of medicine, edited by 
Nicholas A.Boon, 20th edition, reprint 2008, 
pp - 1381, pg - 910. 
2. API text book of medicine, edited by YP 
Munjal, 9th edition, pp- 2165, pg-829. 
3. Fauci, Braunwald, Kasper, Hauser, Longo, 
Jameson - Harrison’s Principles of Internal 
medicine, New York, McGraw-Hill Medical 
Publishing Division, 18th Edition – 2008, 
Volume -II, pp - 2754, pg - 2481. 
4. Agnivesha, Charaka Samhita, Ayurveda 
Deepika Commentary of Chakrapani, edited 
by; Vaidya Yadavji Trikramji Acharya, 
Choukambha Surabharati Prakashan, 
Varanasi, reprint-2011, pp - 738, pg - 251. 
5. Ibid, pp - 738, pg - 552. 
6. Ibid, pp - 738, pg - 553. 
7. Sushruta, Sushruta Samhita, Nibandha 
Samgraha Commentary of Sri 
Dalhanacharya and Nyaya Chandrika 
Panjika on Nidanasthana Commentary of 
Sri Gayadasacharya, by; Vaidya Yadavji 
Trikramji Acharya, Choukambha 
Surabharati Prakashan, Varanasi, reprint-
2008, pp - 824, pg - 704. 
8. Ibid, pp - 824, pg - 705. 
 
*Address for correspondence 
Dr. Chiterlekha 
3rd year PG Scholar  
Dept, of Panchakarma, SKAMCH 
& RC Vijayanagar Bengalore 
Karnataka, India. 
Email: dr.chiterlekha@gmail.com  
Cite this article as:  
Chiterlekha, Swati S. Deshpande, Baidyanath Mishra. Efficacy 
of Pichha Basti in Ulcerative Colitis: An Observational Study. 
Int. J. Ayur. Pharma Research. 2014;2(8):23-26. 
Source of support: Nil, Conflict of interest: None Declared 
 
